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Abstract
NKT cells play important roles in immune surveillance. They rapidly respond to pathogens by detecting microbial glycolipids
when presented by the non-classical MHC I homolog CD1d. Previously, ruminants were considered to lack NKT cells due to
the lack of a functional CD1D gene. However, recent data suggest that cattle express CD1d with unknown function. In an
attempt to characterize the function of bovine CD1d, we assessed the lipid binding properties of recombinant Bos taurus
CD1d (boCD1d) in vitro. BoCD1d is able to bind glycosphingolipids (GSLs) with fatty acid chain lengths of C18, while GSLs
with fatty acids of C24 do not bind. Crystal structures of boCD1d bound to a short-chain C12-di-sulfatide antigen, as well as
short-chain C16-aGalCer revealed that the A pocket of boCD1d is restricted in size compared to that of both mouse and
human CD1d, explaining the inability of long chain GSL’s to bind to boCD1d. Moreover, while di-sulfatide is presented
similarly compared to the presentation of sulfatide by mouse CD1d, aGalCer is presented differently at the cell surface, due
to an amino acid Asp151Asn substitution that results in loss of intimate contacts between the aGalCer headgroup and
CD1d. The altered aGalCer presentation by boCD1d also explains its lack of cross-activation of mouse iNKT cells and raises
the interesting question of the nature and function of bovine lipid-reactive T cells.
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Introduction
CD1 is a family of antigen-presenting molecules that is
structurally related to major histocompatibility class I (MHC I)
molecules, but binds and presents lipids, glycolipids and lipopep-
tides, rather than peptides [1]. In human, five isotypes exist
(CD1a-e). While CD1a-d are differentially expressed at the cell
surface of various cell types, including immature thymocytes,
immature and mature dendritic cells and B cells, CD1e is
exclusively associated with lysosomes where it assists in antigen
processing and loading [2], [3]. CD1 is formed by a heavy chain
that non-covalently associates with beta-2-microglobulin ‘‘light’’
chain (b2m) [4]. A transmembrane domain at the C-terminus of
the heavy chain anchors CD1 to the cell surface and a short
intracellular cytoplasmic tail usually contains amino acid motifs
responsible for the recruitment of adapter proteins and subsequent
intracellular trafficking of CD1 [5]. The heavy chain has three
extracellular domains (a1, a2 and a3). While the a3 domain non-
covalently associates with b2m, the a1 and a2 ectodomains form
the antigen-binding groove that accommodates the lipid anchor of
the antigen, while the polar headgroup, usually a carbohydrate in
case of a glycolipid, is exposed at the surface for recognition by a T
cell receptor (TCR) [4]. The overall architecture of all the CD1
binding grooves is conserved and allows the binding of lipid
antigens that are similar in structure, e.g phosphoglycerolipids that
were acquired in the ER during folding of the nascent CD1 heavy
chain. However, differences in the size, shape and number of the
binding groove forming pockets (A, C, F, T) give rise to distinct
binding properties for unusually long or substituted lipid
backbones [1]. As such, the CD1b isotype can bind antigens with
sizes that exceed the binding capabilities of other CD1 isotypes,
such as found in myolic acids (C55–80), while other binding grooves
are more restricted in size, such as CD1a that can only contain
alkyl chains in the A’ pocket not exceeding C18 [6]. Therefore, it is
likely that each CD1 isotype has evolved to bind a particular class
of lipid antigens, notwithstanding that they also have a overlapping
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such as diacylglycerolipids.
While humans express all 5 CD1 isotypes (CD1a-e), muroid
rodents only express CD1d, while guinea pigs express multiple
isoforms of CD1b and CD1c [7]. Non-primate mammals also lack
some isotypes and/or express multiple variants of certain isotypes
[8,9]. In particular, cattle possess three functional CD1B genes,
called CD1B1, CD1B3 and CD1B5 that differ in their sequence and
shape of the CD1b binding groove and in their cytoplasmic tail
[8,10]. It, therefore, appears that certain species functionally
compensate for the lack of one CD1 isotpye by either expressing
several other isotypes or by using a multifunctional isotype, such as
murine CD1d.
CD1d is the restricting element for Natural Killer T (NKT) cells
that have been widely studied in both humans and mice [11].
There are two major classes of NKT cells. Type I NKT cells are
characterized by the conserved TCR a-chain rearrangement
(Va14Ja18 in mouse and Va24Ja18 in humans) and respond to
the model antigen aGalCer, whereas Type II NKT cells use an
oligoclonal TCR a and TCR b chain repertoire and do not share
a common antigen [12]. However, many of the type II NKT cells
respond to the self-antigen sulfatide [13,14]. Both Type I and II
NKT cells rapidly respond to antigen stimulation and produce
both pro- and anti-inflammatory effector cytokines, such as IL-4
and IFN-y.
It was previously reported that cattle do not express functional
CD1d due to the lack of a start codon [8]. However, a recent study
verified cell surface expression of full-length bovine (bo) CD1d in
cattle [15] and cattle also have the necessary TCR genes to express
NKT cells [16]. This raises the question as to what the antigen is
for boCD1d and whether cattle have functional NKT cells, similar
to humans and mice or use a different CD1d-restricted T cell
population.
In an attempt to shed light onto the ability of boCD1d to
function as an antigen presenting molecule, we have expressed
recombinant boCD1d and used the two well-studied human and
murine NKT cell ligands, sulfatide and a-galactosylceramide
(aGalCer) to characterize their presentation by boCD1d.
Materials and Methods
Oligonucleotides
boCD1d-down: 59-gactgtcgacatgcggtacctaccatggctgttgctgtgg gc-
attcctacaggtctggggacaatctccagccccgcaaacgcc-39.
boCD1ab-up: 59-gaggatccttagtgatggtgatggtgatgccagtagaggatgat-
gtcctgg-39.
b2Mfus-down: 59-atacaattgatccagcgtcctccaaagattc-39.
b2Mfus-up: 59-ttgcggccgcgatgatcctcctccgcttcctgatcctccgcttcctcc-
tcctcccatgtctcgatcccacttaac-39.
boCD1dfus-f: 59-aagcggccgcaagccccgcaaacgcctttc-39.
boCD1dfus-r: 59-ataggatccgcgcggcaccagtccccagtacaggatgatgt-
cctg-39.
mCD1d-D153N-f: 59-tcaaagtgctcaacgctaatcaagggacaagtgca-39.
boCD1d-N151D: 59-caaggtgctcaatcaggaccaagggaccaagga-39.
boCD1d-QN-AD: 59-ggtcatcaaggtgctcaatgcggaccaagggaccaagg-
39.
Cloning, Expression and Purification of Bovine CD1d
The boCD1d ectodomain, in which the endogenous boCD1d
leader sequence was replaced with that of boCD1b3 was amplified
by PCR using the primers boCD1d-down and boCD1ab-up. The
resulting PCR fragment was restricted with SalI and SphI and
ligated into the boCD1b3 containing dual-promotor baculovirus
transfer vector pBACp10pH by replacing the boCD1b3 fragment
[10]. The resulting plasmid contained both boCD1d with a C-
terminal hexa-histidine tag, as well as bovine b2-microglobulin
(bob2M). This construct was used for crystallization.
For functional studies boCD1d was also expressed as a single
chain Fc-fusion protein, in which bob2M (without leader
sequence, amplified using the primers b2M-fus-down and –up)
was connected to the N-terminus of the boCD1d heavy chain
through a (G4S)3 amino acid linker contained within the primer
b2Mfus-up, while the C-terminus of the heavy chain (amplified
with primers boCD1dfus-f and-r) was further fused to the Fc-
region of human IgG1 that had previously been cloned into the
baculovirus transfer vector pAcGP67A (BD Biosciences). The
recombinant soluble bovine CD1d-b2m heterodimeric molecule
without Fc tag was produced to homogeneity using the baculovirus
expression system as previously described for mouse CD1d [17]
and stored at 2806C for lipid loading studies and crystallization.
The single chain boCD1d-Fc fusion protein was purified from a
5 L culture of Spodoptera frugiperda (SF9) insect cells (EMD
Biosciences) that had been infected with the corresponding
recombinant baculovirus at an MOI ,3 for 72h at 27.46C.
Briefly, SF9 cells were removed from the 5 L culture by gentle
centrifugation (1,0006g, 10 min) and the supernatant concentrat-
ed to 300 mL using a tangential flow through filtration device
(Pelllicon 2, Millipore) while exchanging the buffer to PBS. The
boCD1d-Fc fusion protein containing supernatant was passed
through a protein A column (GE Healthcare, Hi Trap
TM rProtein
A), washed with 3 column volumes of PBS and eluted with 20 mM
glycine, 50 mM NaCl, pH 3.0. Fractions of 0.7 ml were collected
into tubes prefilled with 0.3 ml 1 M Tris pH 8.5 for neutraliza-
tion. Fractions containing boCD1d-Fc were analyzed by 4–20%
SDS-PAGE, pooled and buffer exchanged against PBS, using
centrifugal filtration devices (Amicon, 30 kDa molecular weight
cut-off).
Synthesis of C16-aGalCer
(2R,3S,4S)-3,4-di-O-benzyl-1-O-(2,3-di-O-benzyl-4,6-
O-benzylidene-a-D-galactopyranosyl)-2-palmitoyla-
mino-1,3,4-octadecanetriol. To a solution of known azide (1,
Figure 1c) (150 mg, 0.16 mmol) in 1.6 ml tetrahydrofuran (THF)
at room temperature, a 1M solution of PMe3 in THF (1.6 ml,
1.6 mmol) was added dropwise. After stirring for 2.5 h at room
temperature, 2.9 ml of a 1M NaOH solution was added and the
reaction mixture was allowed to stir for an additional 2h. The
reaction was extracted with EtOAc and the combined organic
layer was washed with a saturated aqueous NaCl solution (brine),
dried over Na2SO4, filtered, and evaporated to afford the crude
amine. A mixture of the crude amine, 1-ethyl-3-(3-dimethyllami-
nopropyl)carbodiimide hydrochloride (EDC, 60 mg, 0.31 mmol)
and palmitic acid (80 mg, 0.31 mmol) in 2,4 ml dichloromethane
(DCM) was stirred overnight at room temperature. The reaction
mixture was diluted with DCM, washed with H2O( 2 65 ml) and
brine (165 ml), dried over Na2SO4, filtered, and evaporated to
dryness. Purification of the residue by flash chromatography (silica
gel, hexane:EtOAc 7:3) afforded 131 mg of compound 2
(Figure 1c) (72% yield) as a white solid. Exact mass (ESI-MS) for
C75H108NO9 [M+H]
+ found, 1166.8021 calculated, 1166.8024.
(2R,3S,4S)-1-O-(a-D-galactopyranosyl)-2-palmitoyla-
mino-1,3,4-octadecanetriol (C16:0-aGalCer). A solution of 2
(130 mg, 0.11 mmol) in 4 ml EtOH/CH3Cl 3:1 was hydrogenat-
ed for 1 h under atmospheric pressure in the presence of Pd black
(20 mg). The solution was diluted with 5 ml of pyridine, filtered
through celite and evaporated to dryness. The residue was purified
by flash chromatography (silica gel, DCM:MeOH 9:1) to give
46 mg of compound 3 (58% yield) as a pale yellow solid.
Structural Basis of Lipid Recognition in Cattle
PLOS ONE | www.plosone.org 2 October 2012 | Volume 7 | Issue 10 | e47989Figure 1. Gycolipid binding analysis of boCD1d assessed by native IEF. (A) Chemical structures of the utilized lipids bovine brain sulfatide
(major species C24:1-sulfatide, 1), C12:0-di-sulfatide (2), GT1b (3) and total gangliosides (GM1,G D 1a,G T 1b), with GD1a represented as one major species
(4). The negative charges of the glycolipids are indicated as (-) and correlate with the observed gel shift upon binding to boCD1d represented as
illustrated in (B). (B) native IEF gel illustrating loading of boCD1d with different lipids (left panel), numbered as in (A). Right panel assesses loading
efficiency of C12:0-di-sulfatide (1) with either 36(3:1) or 66(6:1) molar excess of lipid, loaded in the presence (+Tween) or absence of 0.05% Tween 20.
P indicates boCD1b protein used for loading. Length of the fatty acid is indicated for each ligand and represents the major fatty acid of the natural
glycolipids sulfatide (C24:1), total gangliosides (C18:0) and GT1b (C18:0). Of note, only 5% of the fatty acids are shorter than C20:0, while 7% are shorter
than C22:0. (C) Synthesis of C16:0-aGalCer [(2R,3S,4S)-1-O-(a-D-galactopyranosyl)-2-palmitoylamino-1,3,4-octadecanetriol, 3] starting from a known
azide 1, via the intermediate precursor 2.
doi:10.1371/journal.pone.0047989.g001
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PLOS ONE | www.plosone.org 3 October 2012 | Volume 7 | Issue 10 | e479891H NMR (300 MHz, pyridine-d5) d ppm 0.76–1.10 (m, 6 H,
CH3 terminal) 1.15–1.48 (m, 46 H, CH2) 1.61–1.99 (m, 6 H,
CH2) 2.29 (br s, 1 H, OH) 2.46 (t, J=7.4 Hz, 2 H, H-29) 4.25 -
4.49 (m, 6 H, H-30, H-40, H-50, H-3, H-4 and H-60) 4.53 (t,
J=6.2 Hz, 1 H, H-30) 4.57 (d, J=3.1 Hz, 1 H, Ha-1) 4.63–4.73
(m, 2H, Hb-1 and H-20) 5.24–5.34 (m, 1 H, H-2) 5.59 (d,
J=3.7 Hz, 1 H, H-10) 8.48 (d, J=8.5 Hz, 1 H, NH(CO)).
13C NMR (75 MHz, pyridine-d5) d ppm 11.52, 14.60, 14.69,
23.35, 23.62, 24.47, 26.80, 26.92, 29.57, 30.03, 30.16, 30.22,
30.27, 30.34, 30.40, 30.41, 30.44, 30.56, 30.78, 31.08, 32.54,
34.78, 37.21, 39.48, 51.83, 63.08, 68.58, 69.06, 70.71, 71.42,
72.02, 72.91, 73.45, 77.15, 101.94, 173.63.
Exact mass (ESI-MS) for C40H79NNaO9 [M+Na]
+ found,
740.5665 calculated, 740.5653.
In vitro Loading of Lipid Antigens
Brain porcine sulfatide extract, C12-di-sulfatide and total brain
gangliosides were purchased from Avanti Polar Lipids Inc. and
purified trisialoganglioside GT1b from bovine brain was obtained
from Sigma Aldrich (minimum purity 96%). Lipids were dissolved
at 1 mg/ml in DMSO to assess in vitro loading of antigens by
boCD1d. Aliquots of 5 mg of purified boCD1b3 at a concentration
of 10 mM were loaded overnight at room temperature in the
presence of 30 or 60 mM of each ligand (in DMSO, final
concentration of DMSO 3–5%) with or without Tween 20 at a
final concentration of 0.05%. Loading was performed in the
presence of 100 mM TrisHCl pH 7. The binding of charged lipids
was assessed by isoelectric focusing on a PhastGel IEF 3–9 using a
PhastSystem (GE Healthcare) followed by staining with Coomassie
dye.
Protein Crystallization
Crystallization was performed in a 96-well format by a nanoliter
dispensing liquid handling robot (Phoenix, Art Robbins Ltd.) using
commercially available crystallization screens (PEG/Ion I & II,
Wizard I & III, Hampton Research and Emerald Biosciences).
Sitting drops of 100 nl precipitant were overlayed with 100 nl of
protein solution (6.7 mg/ml in 10 mM Hepes, 30 mM NaCl,
pH 7.5). A single diffraction quality crystal of boCD1d-C16-
aGalCer was obtained from the PEG/Ion screen (20% polyeth-
ylene glycol 4000, 0.2 M potassium sulfate) and used for
subsequent data collection. Promising conditions for the
boCD1d-di-SLF complex were optimized manually and diffrac-
tion quality crystals were grown by sitting drop vapor diffusion at
226C, mixing 0.5 ml of protein at 6.7 mg/ml with 0.5 mlo f
precipitant (20% polyethylene glycol 3350, 0.2 M sodium
formate).
Structure Determination and Refinement
Crystals were flash-cooled at 100K in crystallization solution
containing 20% glycerol. Diffraction data of the bo-CD1d-di-SLF
crystal were collected at beamline 5.0.3 of the Advanced
Lightsource (ALS, Berkeley, CA) and data of the boCD1d-C16-
aGalCer crystal were collected at beamline 11.1 at the Stanford
Synchrotron Radiation Lightsource (SSRL, Stanford, CA) and
processed with the HKL2000 software to a resolution of 2.9 A ˚ and
2.4 A ˚, respectively [18]. Molecular replacement was performed
using Phaser [19], and the homology model of boCD1d generated
from the boCD1db3 structure (PDB code 3L9R) using the Swiss
Model server [20]. The asymmetric unit (ASU) of the boCD1d-di-
SLF crystal contained two CD1d-b2m heterodimers, while the
ASU of boCD1d-C16-aGalCer contained one heterodimer. The
initial phases derived from the molecular replacement solution
were refined using maximum-likelihood restrained refinement in
Refmac [21]. Refinement was intercalated with rounds of manual
model building into 2Fo-Fc and Fo-Fc maps in Coot [22]. Tight
NCS constraints between the two boCD1d-di-SLF molecules
present in the ASU were imposed and maintained throughout
refinement. TLS refinement was performed at later stages for the
boCD1d-C16-aGalCer structure in Refmac [21,23]. Three TLS
groups per boCD1d-b2M complex were defined, containing the
a1, a2 domains and the C16-aGalCer ligand (group 1), the a3
domain (group 2) and the b2m chain (group 3). A set of , 1000
reflections (4%) were set aside for the calculation of Rfree to
monitor refinement progress. The quality of the final model was
assessed with Molprobity [24]. Data collection and refinement
statistics are presented in Table 1.
Table 1. Data collection and refinement statistics.
boCD1d-di-SLF boCD1d-C16-aGalCer
Data collection
Space group P 42 P2 12121
Cell dimensions
a, b, c, (A ˚) 168.55, 168.55, 41.53 55.79, 74.48, 122.92
a=b=c (u) 90.00 90.00
Resolution range (A ˚) 50.0–2.90 [3.00–2.90] 40.0–2.40 [2.46–2.40]
Completeness (%) 99.3 [98.4] 97.4 [98.2]
Number of unique reflections 27,330 20,240
Redundancy 3.9 4.1
Rsym (%) 11.4 [58.6] 6.7 [19.9]
I/s
a 17.9 [3.0] 35.0 [4.9]
Refinement statistics
Number of reflections (F.0) 26,175 19,328
Maximum resolution (A ˚) 2.86 2.40
Rcryst (%) 22.2 [26.5] 22.1 [40.1]
Rfree (%) 29.1 [35.3] 27.6 [39.0]
Number of atoms 6,216 3,070
Protein 5,925 2,947
Glycolipid 106 50
N-linked carbohydrate 156 42
Solvent molecules (waters/
sulfate)
29/0 26/5
Ramachandran statistics (%)
Favored 96.8 95.6
Outliers 0.28 0.0
R.m.s.d. from ideal
geometry
Bond length (A ˚) 0.013 0.011
Bond angles (u) 1.52 1.40
Average B values (A ˚ 2)
Protein 44.9 61.0
Glycolipid 70.7 82.8
Water molecules 35.4 52.0
Carbohydrates 77.4 92.0
Numbers in parentheses refer to the highest resolution shell.
doi:10.1371/journal.pone.0047989.t001
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Structure factors and coordinates for the boCD1d-C16-aGalCer
and boCD1d-di-SLF structures have been deposited into the PDB
database (http://www.rcsb.org/) with accession codes 4F7E and
4F7C, respectively.
Cell Free Antigen Presentation Assay
The cell-free Ag presentation assay for stimulation of mouse
iNKT cell hybridomas by recombinant mouse, human and bovine
CD1d was carried out according to published protocols [25,26]
with the following modifications. Briefly, 1 mg soluble hCD1d,
mCD1d, mCD1d Asp153Asn, boCD1d, boCD1d Asn151Asp and
boCD1d Asn151Asp/Gln150Ala proteins were coated in 96-well
flat-bottom plates at 37 uC for 1 h. Plates were blocked for 1 h
with PBS containing 10% FBS and 100ml of glycolipids aGalCer
(KRN7000) or C16-aGalCer (dissolved in 0.05% Tween 20 and
0.9%NaCl) were added to each well at various concentrations and
incubated for 20 h at 37 uC. After washing, 5x10
4 hybridoma cells
in 200 ml complete media were added to each well and incubated
at 37 uC for 16 h in a CO2 incubator. IL-2 release in the
supernatant (100 ml) was measured in a sandwich ELISA, as
previously described [25,26].
Figure Preparation
Lipid structures were prepared in ChemDraw (CambridgeSoft),
all molecular representations were prepared using PyMol
(Schroedinger). Protein cavities were prepared using the fpocket
webserver (http://bioserv.rpbs.univ-paris-diderot.fr/fpocket/)
[27] and visualized in PyMol. Lipid binding groove volumes were
calculated using the CASTp server (http://sts-fw.bioengr.uic.edu/
castp/) [28].
Results
Bovine CD1d can Bind and Present Lipid Antigens in vitro
Bovine CD1d (boCD1d) was previously considered a pseudo-
gene but is translated and expressed at the cell surface, when
transfected into 293 T cells using the native CD1d leader peptide
[8,15]. To investigate whether boCD1d can bind glycolipids in
vitro, we have recombinantly expressed the ectodomain of boCD1d
in insect cells and assessed the glycolipid binding properties of
boCD1d using native isoelectric focusing gel electrophoresis.
Several charged ligands (Figure 1a) were incubated with boCD1d
and successful loading was visualized by native IEF gel (Figure 1b).
Loading of a negatively charged lipid resulted in a gel shift toward
the cathode, caused by the charge difference of the CD1d-lipid
complex. While boCD1d bound C12:0-di-sulfatide, total ganglio-
sides and GT1b, it failed to bind bovine brain sulfatides
(Figure 1B). Besides differences in the headgroups, which generally
do not affect the ability of the antigen to bind to CD1, the
glycolipids only differ in the length and saturation of the fatty acid,
whereas the long chain base (sphingosine) is identical (Figure 1A).
While gangliosides and GT1b contain predominantly C18:0 fatty
acids, di-sulfatide is significantly shorter (C12:0) and the fatty acids
of bovine brain sulfatides typically range from 22 to 24 carbons in
length. This indicated that bovine brain sulfatides could potentially
exceed the chain length for binding to boCD1d. For comparison,
the lipid binding groove of mouse and human CD1d can
accommodate fatty acids with up to 26 carbons in the A’ pocket
[17,29,30]. Next, we tested whether increasing the molar ratio of
C12:0-di-sulfatide and/or including 0.05% Tween 20 detergent
during lipid loading could increase the loading efficiency
(Figure 1B, right panel). Unexpectedly, increasing lipid excess
did not increase loading efficiency, which already appeared
optimal, while in contrast, the addition of Tween 20 prevented
C12:0-di-sulfatide binding altogether. This observation could be
specific for C12:0-di-sulfatide and indicates that this lipid is
predominantly trapped in mixed lipid/detergent micelles, there-
fore being unavailable for loading to boCD1d. BoCD1d ran as a
triplet on the IEF gel, with the majority of the protein migrating as
the center band. Upon addition of Tween 20, however, the middle
band remains unchanged, while the fainter top and bottom bands
disappeared, potentially indicating extraction of single positively
and negatively charged endogenous lipids that had been acquired
during protein expression and folding in the ER of insect cells.
Crystal Structure of boCD1d
To address the question of why boCD1d does not bind bovine
brain sulfatides to a measurable degree, we crystallized boCD1d in
complex with synthetic C12:0-di-sulfatide (di-SLF) and determined
the crystal structure to a resolution of 2.9 A ˚ (Table 1 and
Figure 2A). The obtained structural information encouraged us to
synthesize a shorter form of aGalCer with a C16:0 instead of the
typical C26:0 fatty acid (Figure 1C), which we also crystallized
bound to boCD1d. The crystal structure of the boCD1d-C16:0-
aGalCer complex was determined to a resolution of 2.4 A ˚ (Table 1
and Figure 2B). The asymmetric unit of the boCD1d-di-SLF
crystal contained two separate boCD1d-bob2M-di-SLF complexes
that are very similar, especially in the presentation of the bound
glycolipid. Therefore, we will present structural information for
only one complex. The overall structure of boCD1d is very similar
to that of other CD1 or MHC I molecules, in which the boCD1d
heavy chain is organized in 3 domains, a1 and a2 that form the
central binding groove and a3, which non-covalently associates
with bob2M (Figure 2) [1]. The glycolipids are bound in the
hydrophobic binding groove that can further be divided into the
two main pockets, A and F. While the A pocket binds the acyl
chain of each glycolipid, the F pocket binds the sphingosine,
leaving the structurally distinct carbohydrate headgroups exposed
above the boCD1d binding groove for immune recognition by
cognate T cells (Figure 2). Unambiguous electron density is
observed for the galactosyl-di-sulfate headgroup and the C12:0 fatty
acid of di-sulfatide, while in case of C16:0 -aGalCer, electron
density is well defined for the entire lipid backbone but less well
ordered for the galactose headgroup (Figure 2C, D and Figure S1).
This is in contrast to the well ordered electron density of the
aGalCer headgroup, when presented by either mouse or human
CD1d, indicating that the interaction between the galactose
headgroup and boCD1d is not conserved with that of human or
mouse CD1d [29,30]. Details about the headgroup presentation
by boCD1d will be discussed later.
The boCD1d a1-a2 superdomain (residues 1–180) shares 60%
sequence identity (BLAST search) with human CD1d and 55%
with mouse CD1d. Superposition of the entire boCD1d heavy
chain from the di-sulfatide complex with that of huCD1d and
mCD1d yielded rmsd values of 0.92 A ˚ (PDB 1ZT4) and 1.13 A ˚
(PDB 1Z5L), respectively, indicating a very similar topology of the
boCD1d molecules. Interestingly, superposition of both boCD1d
crystal structures resulted an rmsd of 0.62 A ˚, suggesting a degree
of flexibility of the binding groove when it accommodates different
glycolipids.
Cross-species conserved N-linked oligosaccharides are observed
at residues Asn20 and 42, while the third conserved site on the a2-
helix of CD1d (N163 in human, N165 in mouse) is lost in boCD1d
(H163) (Figure 2).
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Our in vitro lipid loading studies indicated that lipids with fatty
acid chains lengths of 24 carbons or more, such as C24:1-sulfatide
or aGalCer, are unable to bind to boCD1d. As the acyl chain is
bound within the A’ pocket of CD1d, we compared the A’ pockets
of boCD1d containing C12:0-di-sulfatide or C16-aGalCer with
that of human CD1d containing full-length C26:0-aGalCer
(Figure 3A–D). We made two observations that have not been
observed before for any CD1d molecule. Firstly, the shape and size
of the boCD1d A’ pocket differs when either C12:0-di-sulfatide or
C16-aGalCer are bound indicating flexibility within the A’ pocket
(Figure 3B, C). This is a result of a different conformation of the
conserved residue Trp40, which can either increase the size of the
small side pocket, likely induced through contacts with the
terminal carbons of the C12:0 acyl chain of di-sulfatide, or restrict
the size when the longer C16:0 fatty acid is further inserted into the
A pocket. Secondly, the conserved disulfide bond in human and
mouse CD1d that anchors the a2-helix to the b-sheet platform
Figure 2. Overview of the boCD1d-ligand structures. CD1 heavy chain with a1, a2 and a3 domains indicated and b2m are shown in grey. The
bound C12:0-di-sufatide (A) and the C16:0- aGalCer (B) ligands are shown as yellow sticks within the boCD1d binding helices. N-linked
oligosaccharides are shown in green. Binding orientation within the CD1d binding groove and 2FoFc electron density (contoured at 1sand shown
within a 2 A ˚ radius around the glycolipid) is shown as a blue mesh for C12:0-di-sufatide (C) and C16:0-aGalCer (D). A water molecule is shown as a red
sphere in (C). The two major binding pockets A’ and F’ are indicated as such.
doi:10.1371/journal.pone.0047989.g002
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rare rotamer, stabilized by interaction with the side chain of
Thr100, pointing inside the A’ pocket and as such blocking the
remainder of the A’ pocket (Figure 3D). This results in a shorter,
more restricted A’ pocket of boCD1d, which can maximally bind
glycolipid antigens with an acyl chain not exceeding 18 carbons in
length. The restricted A’ pocket also results in a smaller boCD1d
lipid binding groove, which is 1680 A ˚ 3 in volume, compared to
mouse (1970 A ˚ 3) and human (1960 A ˚ 3) CD1d.
Antigen Presentation by boCD1d
The di-sulfo-galactosyl headgroup of di-SLF is presented in the
for b-anomeric glycolipids typical upright orientation, between the
a1- and a2 helices and stabilized through an intricate network of
H-bonds that involve the core residues of CD1d (Arg79, Asp80,
Asn151 and Thr154), as well as the polar moieties of the di-SLF
ligand (Figure 4A). The 39-SO4 group contacts Asn151, while the
69-SO4 group is bound through a water-mediated hydrogen (H)
bond to Arg79. The ceramide lipid backbone is oriented inside the
binding groove by an H-bond between Thr154 and the N-amide
nitrogen, as well as by Asp80 of CD1d binding the 30-OH group of
sphingosine. A total of 6 H-bonds are formed between boCD1d
and di-SLF (four with the headgroup and two with the lipid),
which gives rise to ordered electron density for the headgroup
(Figure 2C). Overall, the orientation of di-SLF in the boCD1d
binding groove, and the presentation at the opening of the groove
is conserved with the presentation of sulfatide by mCD1d
(Figure 4C).
As human and mouse iNKT cells are cross-reactive in regards
to aGalCer, we investigated whether the presentation of C16:0-
aGalCer by boCD1d is altered compared to that of either human
or mouse CD1d. Indeed, the binding and presentation of C16:0-
aGalCer is not conserved with that of either mouse or human
CD1d (Figure 4B, D). BoCD1d presents C16:0-aGalCer in an
untypically tilted orientation. The only polar interactions between
C16:0-aGalCer and boCD1d is through a1-helix residue Arg79
that interacts with the 29-OH of galactose, as well as the contact
formed between Asp80 and the 30-OH of the phytosphingosine
chain. Loss of the intimate contacts between the a-anomeric
galactose and the a ,helix is likely caused by the exchange of
Asp151 to Asn151. This otherwise conserved aspartate residue on
the a2-helix (Asp 151 in hCD1d and Asp153 in mCD1d) is critical
for the presentation of aGalCer and related antigens, by CD1d, as
it binds the 20- and 30-OH of the galactose in human and mCD1d
and substitutions to either tyrosine or alanine abrogate iNKT cell
activation [31] (and data not shown).
We next assessed, whether mutating Asp153 of mouse CD1d to
Asn (as found in boCD1d) alone is sufficient for the loss of mouse
iNKT cell activation and conversely, if re-constitution of Asp151
residue in boCD1d (to mimic mouse and human CD1d) can
restore mouse iNKT cell activation in a cell-free antigen-
presentation assay (Figure 5). We also prepared the boCD1d
Figure 3. Architecture of the A’ pocket of boCD1d. The A’ pocket of human CD1d with bound C16:0-aGalCer (A), boCD1d with bound C12:0-di-
sufatide (B) and C16:0-aGalCer (C) is shown as a semi-transparent molecular surface colored in mauve. CD1d residues that influence the shape of the
groove are indicated as grey sticks. (D) Superposition of the A’ pocket of boCD1d and huCD1d, with C12:0-di-sufatide (yellow), C16:0-aGalCer (grey) and
C26:0-aGalCer (green, from PDB ID 1ZT4) shown. While Trp40 (W40) adopts different orientations in both boCD1d structures, which influences the
shape of the small side pocket, Trp166 (W166) blocks the second half of the A’ pocket and restricts the ligand size to 16–18 carbons. Trp166 is a
cysteine in both human and mouse CD1d (C102-C166 in green/yellow) that is involved in a disulfide bond with Cys102 located on the b-sheet (C).
Sequence alignment of the binding groove forming residues of bovine (bo), human (hu) and murine (mu) CD1d (bottom panel). Red boxed residues
are conserved in all three species, while yellow boxed residues are conserved between boCD1d and either human or mouse CD1d. Residues that
represent features that are not conserved in boCD1d are colored blue (e.g. A’ pole; G12, L70, C102-C166 disulfide bond, N151 which is important for
aGalCer headgroup binding and both Trp40 and Trp166 that influcne the shape of the groove).
doi:10.1371/journal.pone.0047989.g003
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mouse CD1d residue in an area that is in close contact with the
CDR3b loop of the mouse iNKT cell hybridoma 2C12 [32].
While both human and mouse CD1d can activate the two mouse
iNKT cell hybridomas 2C12 as well as 1.2 by presenting either
full-length aGalCer or C16-aGalCer, the mCD1d Asp153Asn
mutant and all the bovine CD1d proteins (wt and mutants) are
unable to activate both mouse iNKT cell hybridomas (Figure 5,
and data not shown). Both hybridomas respond equally well to
aGalCer when presented by either human or mCD1d, while 1.2 is
activated better when C16-aGalCer is presented by human CD1d.
Our data further indicates that alteration of Asp153 of mouse
CD1d is not tolerated, not even when replaced with similar amino
acids, such as asparagine, thereby explaining the inability of
boCD1d to activate murine NKT cell. However, replacing
Asn151 of boCD1d with aspartate does not reconstitute cross-
species reactivity, indicating that other amino acids that differ
between mouse and bovine CD1d likely are equally important for
either optimal glycolipid presentation or iNKT TCR binding to
CD1d. Surprisingly, however, superposition of bovine CD1d onto
the structure of the mouse CD1d-aGalCer –Va14Vb8.2 TCR
complex (PDB ID 3HE6) [33], as well as the human ortholog
complex (PDB ID 3HUJ) [34], did not reveal any other obvious
amino acids that are conserved between mouse and human CD1d
but differ with boCD1d, and which would prevent binding of the
mouse iNKT TCR onto boCD1d, raising the question as to what
residues actually limit cross-species reactivity.
Discussion
In contrast to earlier studies we could now show that cattle
express CD1d protein that is able to traffic to the cell surface for
antigen display [15]. In vitro binding studies indicated that
glycolipids that exceed the alkyl chain length of C18 do not bind to
boCD1d. Our structural studies using a short chain C12-di-
sulfatide finally revealed that boCD1d has a restricted A’ pocket,
which in contrast to mouse and human CD1d, can maximally
bind glycolipids with alkyl chain lengths approximating C18. Not
surprisingly, no increase in body temperature or serum cytokine
levels (signs of immune activation) were observed when injecting
full-length aGalCer into cattle, as it cannot be presented by
boCD1d. However, human NKT cells responded weakly to both
shorter versions of aGalCer (C12 and C16) [15], suggesting that the
in vivo response against aGalCer should be re-assess using the
shorter variants.
In an attempt to decipher the structural basis of glycolipid
antigen-presentation by boCD1d, we determined the crystal
structure of boCD1d presenting C16-aGalCer. We found that
aGalCer is presented differently by boCD1d, due to the exchange
of a single aspartate amino acid (to asparagine) that is otherwise
Figure 4. Antigen presentation by boCD1d. Presentation of the headgroups of C12:0-di-sufatide (A) and C16:0-aGalCer (B) above the boCD1d
binding groove and comparison with mouse CD1d presented sulfatide (C) and mouse and human CD1d presented aGalCer (D). Glycolipids presented
by boCD1d as yellow, mouse CD1d as green and human CD1d as cyan sticks. Note, how di-sulfatide is bound across the binding groove and in
contact with both CD1d residues of the a1 and a2 helix, boCD1d–presented aGalCer looses intimate contacts with N151 and exclusively contact
a1helix residues (R79 and D80), resulting in a more tilted headgroup presentation.
doi:10.1371/journal.pone.0047989.g004
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further reveals that asparagine, though similar in size, does not
form intimate contacts with the galactose of aGalCer and, thus,
aGalCer is presented more tilted at the opening of the boCD1d
binding groove. Superposition of mouse, human and boCD1d
presenting aGalCer reveals that boCD1d presents aGalCer more
similar to human CD1d, thus likely explaining the slight cross-
species activation of human NKT cells, however the binding
chemistries between human and bovine CD1d are different. For
human CD1d, the bulky trypophane side (Trp153) leads to the
tilting of the galactose, while still maintaining the two important H
bonds between Asp151 and the 20 and 30-OH of galactose [29],
while bovine CD1d (as well as mouse CD1d) has a glycine residue
at this position and the lack of forming the equivalen H bonds with
Asn151 in boCD1d likely lead to the altered and tilted aGalCer
presentation. The importance of the Asp151 sidechain has further
been demonstrated by mutagenesis studies using mouse CD1d.
Mutation of the equivalent Asp153 to asparagine leads to complete
loss of iNKT cell activation further demonstrating why boCD1d is
unable to activate mouse iNKT cells when presenting short-chain
aGalCer. However, aGalCer itself is an unphysiological antigen,
which mimics natural ligands for mouse and human iNKT cells.
While mouse and human iNKT cells are evolutionary conserved
and generally respond to the same antigens, this is not true for the
more recently identified microbial antigens. Especially for Borrelia
burgdorferi a-galactosyl diacylglycerol (aGalDAG) lipids, the precise
nature of the diacylglycerol backbone determines antigenicity for
human and mouse iNKT cells. Two aGalDAG species were
identified that differ only in the fatty acid composition. While the
antigen BbGL-2c (C18:1/C16:0) activates mouse iNKT cells but not
human, BbGL-2f (C18:2/C18:1) activates only human iNKT cells
[25,35]. Therefore, it is possible that bovine pathogens differ in
their lipid composition compared to human and mouse pathogens
and as a result cattle have evolved lipid-reactive and boCD1d-
restricted T cells that are likely different from human or mouse
iNKT cells. This notion is further supported by the different size
and shape of the A’ pocket of boCD1d, which allows for the
binding of the majority of microbial diacylglycerolipids, which
generally contain fatty acids with 16–18 carbons in length. In
contrast, many glycosphingolipids, such as aGalCer, commonly
incorporate long chain fatty acids ranging in length between 24
and 26 carbons, which would exceed the size of the boCD1d
molecule. Therefore, boCD1d cannot present the same range of
antigen as human and mouse CD1d can. The only other species
for which CD1 crystal structures are available is chicken. Both
chicken (ch)CD1-1 and chCD1-2 have been crystallized with
endogenously bound lipids and the structures reveal two extremes
in terms of size and shape of the hydrophobic binding groove,
Figure 5. Activation of mouse NKT cells by CD1d orthologs. Activation of mouse iNKT hybridomas 1.2 by recombinant human, mouse and
bovine CD1d in a CD1d-coated plate assay, using either aGalCer (top) or C16-aGalCer (C16, bottom). Individual amino acid mutations in CD1d are
indicated. Concentrations of glycolipids used to load plate bound CD1d ranges from 0–5 mg/ml as indicated. iNKT cell activation is measured by the
release of IL-2 in an ELISA assay. Experiment was performed twice, while measuring each condition in triplicate.
doi:10.1371/journal.pone.0047989.g005
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[36,37]. While chCD1-2 has a primitive single pore suitable for
binding of single chain lipids or fatty acids [37], chCD1-1 has an
elaborate binding groove suitable to accommodate dual and
possibly tri-acylated lipids [36]. Thus changes in size and shape of
the binding groove likely reflect the encounter with different lipid
structures from different pathogens during the course of CD1
evolution.
We further observed structural flexibility within the A’ pocket
that can change the shape of the pocket. It is conceivable that this
allows the accommodation of small acyl chain modifications, such
as hydroxyl or methyl groups, which are found in different lipids or
fatty acids such as tuberculostearic acid. Furthermore, lack of
human T cell activation by bovine CD1 has also been seen for
another bovine CD1 isotype, boCD1b3, which is unable to
activate the human CD1b-restricted T cell line LDN5 when
presenting glucose monomycolate [10], indicating that lipid
reactive T cells in cattle differ from that of mouse and man.
Supporting Information
Figure S1 Antigen omit map electron density. FoFc
difference electron density omit maps were calculated before
glycolipid fitting and are contoured at 3s as a green mesh drawn
around the headgroups of C12:0-di-sufatide and C16:0-aGalCer.
(TIF)
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